Gilead faces legal action in Massachusetts if it doesn’t cut hep C prices: State AG

Tracy Staton
Sciences is facing more hepatitis C pushback from officials. The attorney general is warning that it will take against the California-based company if it doesn’t cut the price of its blockbuster antivirals Sovaldi and Harvoni.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS